Bank of New York Mellon’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50M | Sell |
|
|||||
|
2025
Q2 | $46.9M | Buy |
|
|||||
|
2025
Q1 | $66.6M | Sell |
|
|||||
|
2024
Q4 | $29.7M | Sell |
|
|||||
|
2024
Q3 | $28M | Sell |
|
|||||
|
2024
Q2 | $22M | Sell |
|
|||||
|
2024
Q1 | $18.2M | Sell |
|
|||||
|
2023
Q4 | $25.1M | Sell |
|
|||||
|
2023
Q3 | $22.7M | Sell |
|
|||||
|
2023
Q2 | $19M | Sell |
|
|||||
|
2023
Q1 | $20.1M | Buy |
|
|||||
|
2022
Q4 | $18.6M | Sell |
|
|||||
|
2022
Q3 | $25.6M | Buy |
|
|||||
|
2022
Q2 | $22.8M | Sell |
|
|||||
|
2022
Q1 | $22.5M | Sell |
|
|||||
|
2021
Q4 | $20.5M | Sell |
|
|||||
|
2021
Q3 | $21.5M | Buy |
|
|||||
|
2021
Q2 | $23.8M | Sell |
|
|||||
|
2021
Q1 | $25.7M | Sell |
|
|||||
|
2020
Q4 | $28.4M | Sell |
|
|||||
|
2020
Q3 | $19.8M | Sell |
|
|||||
|
2020
Q2 | $19.5M | Sell |
|
|||||
|
2020
Q1 | $13.8M | Sell |
|
|||||
|
2019
Q4 | $14.7M | Sell |
|
|||||
|
2019
Q3 | $17.4M | Sell |
|
|||||
|
2019
Q2 | $14.2M | Sell |
|
|||||
|
2019
Q1 | $15M | Sell |
|
|||||
|
2018
Q4 | $17.9M | Buy |
|
|||||
|
2018
Q3 | $18.2M | Buy |
|
|||||
|
2018
Q2 | $18.8M | Buy |
|
|||||
|
2018
Q1 | $19.5M | Sell |
|
|||||
|
2017
Q4 | $27.7M | Buy |
|
|||||
|
2017
Q3 | $18.3M | Buy |
|
|||||
|
2017
Q2 | $10.9M | Buy |
|
|||||
|
2017
Q1 | $9.7M | Buy |
|
|||||
|
2016
Q4 | $3.27M | Buy |
|
|||||
|
2016
Q3 | $2.21M | Buy |
|
|||||
|
2016
Q2 | $1.75M | Buy |
|
|||||
|
2016
Q1 | $1.27M | Sell |
|
|||||
|
2015
Q4 | $1.41M | Buy |
|
|||||
|
2015
Q3 | $1.02M | Sell |
|
|||||
|
2015
Q2 | $1.95M | Buy |
|
|||||
|
2015
Q1 | $1.39M | Sell |
|
|||||
|
2014
Q4 | $779K | Sell |
|
|||||
|
2014
Q3 | $741K | Sell |
|
|||||
|
2014
Q2 | $776K | Buy |
|
|||||
|
2014
Q1 | $1.09M | Buy |
|
|||||
|
2013
Q4 | $770K | Buy |
|
|||||
|
2013
Q3 | $367K | Buy |
|
|||||
|
2013
Q2 | $398K | Buy |
|